Aquapick Whitening Bubblepick

Description

The product is identified by SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, which is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for use in specific patient populations as determined by clinical guidelines. Currently, there are no detailed indications or usage specifications provided. Healthcare professionals are advised to refer to the latest clinical data and guidelines for appropriate prescribing information. There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The product is indicated for dental use only. Healthcare professionals should ensure that the administration is restricted to the oral cavity and that appropriate precautions are taken to avoid exposure to non-dental tissues.

Dosing should be determined based on the specific clinical scenario and patient needs, adhering to established guidelines for dental procedures. It is essential to follow the recommended dosing intervals and administration techniques to ensure optimal therapeutic outcomes while minimizing potential adverse effects.

Preparation of the product should be conducted in accordance with standard protocols for dental applications, ensuring sterility and proper handling. The healthcare professional should monitor the patient for any immediate reactions following administration and provide appropriate follow-up care as necessary.

Contraindications

Use is contraindicated in individuals who are unable to keep the product out of reach of children. This precaution is necessary to prevent accidental ingestion or misuse by pediatric patients. No other contraindications have been identified.

Warnings and Precautions

Children under the age of 6 should be supervised by an adult when using this product. It is recommended that they use no more than a pea-sized amount to minimize the risk of overconsumption. In the event of overconsumption, it is imperative to contact a qualified medical professional immediately for guidance.

This product is intended solely for oral hygiene purposes. Users should avoid sucking or swallowing the product to ensure safe usage.

In the case of any adverse effects or side effects, it is crucial to seek immediate advice from a qualified medical or dental professional. Prompt attention to any unexpected reactions is essential for the safety and well-being of the user.

Side Effects

Patients should be aware that if any side effects occur, it is essential to contact a qualified medical or dental professional immediately. This warning underscores the importance of monitoring for adverse reactions and seeking timely medical advice to ensure safety and appropriate management.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Aquapick Whitening Bubblepick (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under the age of 6 should be accompanied by an adult when using this product. It is recommended that they use no more than a pea-sized amount. In the event of overconsumption, it is imperative to contact a qualified medical professional immediately. Additionally, pediatric patients should be cautioned against sucking or swallowing the product.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of AQUAPICK WHITENING BUBBLEPICK during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Healthcare professionals should consider the absence of data when advising women of childbearing potential and weigh the potential risks and benefits of using this product during pregnancy.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for AQUAPICK WHITENING BUBBLEPICK. Therefore, healthcare professionals should exercise caution when recommending this product to lactating mothers. The potential effects on breastfed infants have not been established, and further research may be necessary to determine safety during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In cases of overdosage, it is crucial to adhere to specific guidelines to ensure the safety of pediatric patients. Children under the age of 6 should always be accompanied by an adult when using this product. It is recommended that they use no more than a pea-sized amount to minimize the risk of overconsumption.

Should overconsumption occur, immediate action is necessary. Healthcare professionals should be contacted without delay for further evaluation and management. Prompt medical attention is essential to address any potential adverse effects associated with the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage and handling to ensure the safety of young individuals.

Storage and Handling

This product is supplied in a plastic bottle, ensuring ease of use and storage. It is essential to keep the product out of reach of children and to use it solely for oral hygiene purposes. There are no specific temperature or light protection instructions provided, allowing for flexible storage conditions.

Additional Clinical Information

The product is administered via the dental route. Clinicians should counsel patients to keep the product out of reach of children. For children under the age of 6, adult supervision is required during use, and they should use no more than a pea-sized amount. In the event of overconsumption, patients are advised to contact a qualified medical professional immediately. It is important to avoid sucking or swallowing the product, as it is intended for oral hygiene purposes only. Patients should also be informed to report any side effects to a qualified medical or dental professional promptly.

Drug Information (PDF)

This file contains official product information for Aquapick Whitening Bubblepick, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)